Dri Healthcare Trust T.DHT.UN

Alternate Symbol(s): DHTRF

Healthcare Biotechnology

DRI Healthcare Trust is an open-ended trust that provides unitholders with differentiated exposure to the anticipated growth in the global pharmaceuticals and biotechnology markets. Its business model is focused on managing and growing a diversified portfolio of pharmaceutical royalties to deliver attractive growth in cash royalty receipts over the long term. Geographically, it has a presence in the United States; European Union; Japan, and Rest of the world.

TSX:DHT.UN - Post by User

Dri Healthcare Trust > Revised Targets

<< Previous

Bullboard Posts

Next >>

Post by retiredcfon Sep 21, 2023 7:04am

162 Views

Post# 35646880

Revised Targets

Canaccord Genuity’s Tania Armstrong-Whitworth cut her DRI Healthcare Trust target to $16.25 from $17 with a “buy” rating, while CIBC’s Scott Fletcher lowered his target to $18 from $20 with an “outperformer” rating. The average is $18.25.

<< Previous

Bullboard Posts

Next >>

Global Tungsten Market and Supply Security